#lancet — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #lancet, aggregated by home.social.
-
https://www.europesays.com/it/669777/ Il cervello si protegge prima che la memoria inizi a perdere colpi: le abitudini che possono fare la differenza #AttivitàFisica #demenza #diabete #fumo #Health #ipertensione #IT #Italia #Italy #lancet #Obesità #OrganizzazioneMondialeDellaSanità #prevenzione #Salute #sonno
-
Whose Distress, Whose Diagnosis? Lancet Perspectives Piece Questions Who Defines Psychological Suffering
https://1ban.news/whose-distress-whose-diagnosis-lancet-nadkarni/
#1ban #whose #distress #diagnosis #lancet #science -
Polycystic ovary syndrome (#PCOS) was officially renamed Polyendocrine Metabolic Ovarian Syndrome (#PMOS) on May 12, 2026,. This change, published in The #Lancet and announced at the European Congress of Endocrinology, followed a rigorous 14-year global consensus process. The update aims to reduce stigma, improve diagnosis, and accurately reflect the condition's complex, multi-system nature beyond just the ovaries.
This is huge news for women, as it’s estimated that up to a third of women experience some PMOS symptoms. The previous nomenclature meant that many women were not being diagnosed correctly. As a matter of #bioethics of women’s treatment, this is a big sea change. As to how it changes medical professional’s approach, we will have to determine.
The Lancet:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00717-8/fulltextThe Endocrine Society: https://www.endocrine.org/news-and-advocacy/news-room/2026/pcos-name-change
-
Deprivation linked to higher second cancer risk among England breast cancer survivors | Cancer | The Guardian
https://www.theguardian.com/society/2024/apr/25/deprivation-linked-to-higher-second-cancer-risk-among-england-breast-cancer-survivors#Deprivation
#BreastCancer
#RiskOf2ndCancer
#CambridgeUni
#Inequalities
#Lancet
#HealthInequalities
#CatchUpWithCancer
#BreastCancerNow
#SecondPrimaryCancer
#SecondaryCancer
#Poverty -
Headline result from the #Sparsentan PROTECT trial in #IgANephropathy in #Lancet https://authors.elsevier.com/c/1grIl_3CjG8WAP
1/🧵
Full text link via @Rheault_m
Big proteinuria reduction: